Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Obesity

Free Subscription Articles published in Diabetes Metab Retrieve available abstracts of 21 articles: HTML format

Single Articles

January 2025
1. YUAN F, Fang D, Xu H, Nie Y, et al
   One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals.
   Diabetes Metab. 2025;51:101588.
   PubMed     Abstract available
   
   
   December 2024
2. BROUSSE Y, Gerardin P, Filali D, Lenclume V, et al
   Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020-2021.
   Diabetes Metab. 2024;51:101601.
   PubMed     Abstract available
   
   
   September 2024
3. WEAN J, Baranwal S, Miller N, Shin JH, et al
   Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss.
   Diabetes Metab. 2024;50:101570.
   PubMed     Abstract available
   
   
   
4. KOVAC L, Gancheva S, Jahnert M, Sehgal R, et al
   Different effects of bariatric surgery on epigenetic plasticity in skeletal muscle of individuals with and without type 2 diabetes.
   Diabetes Metab. 2024;50:101561.
   PubMed     Abstract available
   
   
   December 2023
5. KOUIDRAT Y, Collen LL, Vaxillaire M, Dechaume A, et al
   Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine.
   Diabetes Metab. 2023 Dec 21:101507. doi: 10.1016/j.diabet.2023.101507.
   PubMed     Abstract available
   
   
   November 2023
6. LAFARGE JC, Aron-Wisnewsky J, Pattou F, Cucherat M, et al
   French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission- a meta-analysis in patients with class I to III obesity.
   Diabetes Metab. 2023 Nov 22:101495. doi: 10.1016/j.diabet.2023.101495.
   PubMed     Abstract available
   
   
   May 2023
7. YANG Z, Shen P, Qu Y, Xu L, et al
   Baseline and longitudinal trajectories of body-mass index and all-cause mortality among patients with type 2 diabetes.
   Diabetes Metab. 2023;49:101426.
   PubMed     Abstract available
   
   
   March 2023
8. AMADOU C, Heude B, de Lauzon-Guillain B, Lioret S, et al
   Early origins of metabolic and overall health in young adults: An outcome-wide analysis in a general cohort population.
   Diabetes Metab. 2023;49:101414.
   PubMed     Abstract available
   
   
   July 2022
9. RIVIERE B, Jaussent A, Macioce V, Faure S, et al
   The triglycerides and glucose (TyG) index: A new marker associated with nonalcoholic steatohepatitis (NASH) in obese patients.
   Diabetes Metab. 2022;48:101345.
   PubMed     Abstract available
   
   
   June 2022
10. VALENZUELA-VALLEJO L, Chrysafi P, Mantzoros CS
    Liraglutide-induced effects on energy intake and glycemic profile are independent of total and intact GDF-15 levels in subjects with obesity and diabetes.
    Diabetes Metab. 2022 Jun 28:101369. doi: 10.1016/j.diabet.2022.101369.
    PubMed    
    
    
    
11. LEMBO E, Russo MF, Verrastro O, Anello D, et al
    Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes.
    Diabetes Metab. 2022 Jun 24:101363. doi: 10.1016/j.diabet.2022.101363.
    PubMed     Abstract available
    
    
    May 2022
12. XI Y, Gao W, Zheng K, Lv J, et al
    Overweight and risk of type 2 diabetes: A prospective Chinese twin study.
    Diabetes Metab. 2022;48:101278.
    PubMed     Abstract available
    
    
    January 2022
13. KUMAR S, Khatri M
    Response to "A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass".
    Diabetes Metab. 2022;48:101302.
    PubMed     Abstract available
    
    
    
14. MORICONI D, Manca ML, Anselmino M, Rebelos E, et al
    Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: A ten-year follow-up study.
    Diabetes Metab. 2022;48:101282.
    PubMed     Abstract available
    
    
    
15. BI J, Song L, Wang L, Su B, et al
    Transitions in metabolic health status over time and risk of heart failure: A prospective study.
    Diabetes Metab. 2022;48:101266.
    PubMed     Abstract available
    
    
    November 2021
16. BREDER I, Wolf VLW, Soares AAS, de Carvalho LSF, et al
    Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: an active-controlled randomised trial.
    Diabetes Metab. 2021 Nov 19:101304. doi: 10.1016/j.diabet.2021.101304.
    PubMed    
    
    
    March 2021
17. PRANATA R, Lim MA, Yonas E, Vania R, et al
    Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.
    Diabetes Metab. 2021;47:101178.
    PubMed     Abstract available
    
    
    
18. LEON-MIMILA P, Villamil-Ramirez H, Li XS, Shih DM, et al
    Trimethylamine N-oxide levels are associated with NASH in obese subjects with type 2 diabetes.
    Diabetes Metab. 2021;47:101183.
    PubMed     Abstract available
    
    
    
19. LI F, Duan J, Yang Y, Yan G, et al
    Distinct uric acid trajectories are associated with incident diabetes in an overweight Chinese population.
    Diabetes Metab. 2021;47:101175.
    PubMed     Abstract available
    
    
    September 2020
20. MONNIER L, Schlienger JL, Colette C, Bonnet F, et al
    The obesity treatment dilemma: Why dieting is both the answer and the problem? A mechanistic overview.
    Diabetes Metab. 2020 Sep 28. pii: S1262-3636(20)30127.
    PubMed     Abstract available
    
    
    February 2020
21. BOTHOU C, Beuschlein F, Spyroglou A
    Links between aldosterone excess and metabolic complications: A comprehensive review.
    Diabetes Metab. 2020;46:1-7.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obesity is free of charge.